arrow_backBack to Catalogue
GH Secretagogue
Tesamorelin
Potent GHRH analog specifically targeted for reducing visceral fat.
Clinical Profile
- check_circleSelective reduction of visceral adipose tissue
- check_circleImprovement in lipid profiles and triglycerides
- check_circlePreservation of healthy metabolic markers
- check_circleClinically proven pituitary stimulation
biotech
Mechanism of Action
A stabilized growth hormone-releasing hormone (GHRH) analog. It is uniquely effective at selectively reducing visceral adipose tissue (deep belly fat) without affecting subcutaneous fat or causing metabolic disruptions.
medication_liquid
Therapeutic Application
Subcutaneous injection administered daily, typically in the abdominal region.
Ready to include Tesamorelin in your protocols?
Log in to the prescriber portal to access research monographs, inventory availability, and peer-reviewed clinical studies.